Skip to content
AnalystLens
Back to MRNABalance Sheet

Moderna, Inc. Current Liabilities 2017-2026 | MRNA

Annual FY2017–FY2025 · quarterly through Q1 FY2026

Latest annual · FY2025

$1.99B

−9.9%YoY vs FY2024Source: 10-KFY2025

From $191.5M in FY2017 to $1.99B in FY2025: 10.4× in 8 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26$2.4B+49.3%Not reportedNot reportedNot reported
FY25$1.6B−32.6%$1.6B−33.5%$1.7B−23.6%$2.0B−9.9%
FY24$2.4B−32.0%$2.4B−24.3%$2.2B−49.8%$2.2B−26.8%
FY23$3.5B−62.1%$3.1B−54.2%$4.4B−35.6%$3.0B−38.8%
FY22$9.2B+9.4%$6.8B−22.9%$6.8B−31.6%$4.9B−46.1%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date.

Key Statistics

Trend DirectionDeclining
CAGR

−14.7%

FY2020
$4.39B
FY2025
$1.99B

5 years selected · on the chart

01—History

Current Liabilities History

Year-over-year comparison from 10-K annual reports

  9. $1.99B
YoY changeLargest recent move+108.0%in FY21Latest −9.9%

1 older move runs past ±150% (largest +2966.8%); point at, tap or drag across the bars to read one.

02—Ledger

Current Liabilities, period by period

PeriodValueChangeSource
FY2025$1.99B−9.9%10-K
FY2024$2.21B−26.8%10-K
FY2023$3.02B−38.8%10-K
FY2022$4.92B−46.1%10-K
FY2021$9.13B+108.0%10-K
FY2020$4.39B+2966.8%10-K
FY2019$143.1M−35.8%10-K
FY2018$222.8M+16.4%10-K
FY2017$191.5M—10-K

03—Questions

What is current liabilities?

Current liabilities are obligations expected to be settled within one year or the normal operating cycle of the business.

What is Moderna, Inc.'s current current liabilities?

Moderna, Inc. (MRNA) annual current liabilities for 2025 was $1.99B, a 9.93% decline from 2024. Moderna, Inc. current liabilities for the quarter ending March 31, 2026 was $2.40B.

What was Moderna, Inc.'s current liabilities in 2024?

Moderna, Inc. annual current liabilities for 2024 was $2.21B, a 26.83% decline from 2023.

What was Moderna, Inc.'s current liabilities in 2023?

Moderna, Inc. annual current liabilities for 2023 was $3.02B, a 38.76% decline from 2022.

What is Moderna, Inc.'s 5-year current liabilities CAGR?

Moderna, Inc. current liabilities grew at a compound annual growth rate (CAGR) of 14.66% from FY2020 to FY2025, going from $4.39B to $1.99B over 5 years.

Company
Moderna, Inc.
Ticker
MRNA
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)
View company profile →